Verastem, Inc. (NASDAQ:VSTM) is one of the top long-term biotechnology stocks to buy. On October 23, Verastem, Inc.

One of Lamm’s most effective critics – Vincent Lynch, an expert on evolutionary genetics at the University at Buffalo – has been the target of all three forms of attack. Lamm denies responsibility for ...

Learn more about whether Alkermes plc or Arcus Biosciences, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Icotrokinra demonstrated clinically meaningful outcomes at Week 28 in the Phase 2b ANTHEM-UC study in ulcerative colitis, with 31.7% of patients achieving clinical remission and 38.1% showing ...

Lady Purple was awarded Gold during the latest Pure Beauty Awards 2025 as the Best New Ingredient. This article dives deep ...

Inflarx N.V. (($IFRX)) announced an update on their ongoing clinical study. Study Overview: The JUST BREATHE study, ...

First five patients in Part C (expansion) of THIO-101 Phase 2 clinical trial enrolled in Taiwan and Turkey CHICAGO, (GLOBE ...

NT-0796 is an oral, brain-penetrant NLRP3 inhibitor that selectively regulates chronic inflammation, a key driver of cardiometabolic diseases ...

Growing consensus is emerging that artificial intelligence (AI) may assist biotechnology and life sciences companies to draft ...

Obesity has now reached pandemic proportions.1,2 WHO coined the term globesity to characterise its relentless rise worldwide ...